Antidepressant use and colorectal cancer risk
- 21 July 2009
- journal article
- research article
- Published by Wiley in Pharmacoepidemiology and Drug Safety
- Vol. 18 (11), 1111-1114
- https://doi.org/10.1002/pds.1808
Abstract
Purpose A previous epidemiologic study reported a 30% reduced risk of colorectal cancer among users of high doses of selective serotonin reuptake inhibitors (SSRIs). We assessed the association of colorectal cancer risk with SSRI and tricyclic antidepressant use in our hospital‐based Case Control Surveillance Study. Methods For the SSRI analyses, we used data collected on 529 colorectal cancer cases and 1955 hospitalized controls collected from 1995 to 2008. For the tricyclic antidepressant analyses, we used data on 2889 cases and 7122 controls collected from 1976 to 2008. We used multivariable logistic regression analysis to evaluate the association of regular SSRI use and regular tricyclic antidepressant use (daily use for at least 3 continuous months) with colorectal cancer risk. Results The odds ratio for regular SSRI use was 0.55 (95% CI 0.35–0.88) and it did not differ by duration of use. The odds ratio was 0.47 (95% CI 0.26–0.85) for colon cancer and 0.72 (95% CI 0.37–1.41) for rectal cancer. The odds ratio for regular use of tricyclic antidepressants was 0.77 (95% CI 0.52–1.16) Conclusions We found an association of reduced risk of colorectal cancer with regular use of SSRIs. In light of laboratory data indicating that SSRIs may inhibit colon cancer and one previous epidemiologic study that also observed a decreased risk, further investigation of the effect of SSRIs on the risk of colorectal cancer is warranted. Copyright © 2009 John Wiley & Sons, Ltd.Keywords
This publication has 14 references indexed in Scilit:
- Serotonin Regulates Macrophage-Mediated Angiogenesis in a Mouse Model of Colon Cancer AllograftsCancer Research, 2008
- Desipramine Induces Apoptotic Cell Death through Nonmitochondrial and Mitochondrial Pathways in Different Types of Human Colon Carcinoma CellsPharmacology, 2007
- Statin Use and the Risk of 10 CancersEpidemiology, 2007
- Characterization of cytotoxic actions of tricyclic antidepressants on human HT29 colon carcinoma cellsEuropean Journal of Pharmacology, 2006
- Use of antidepressants and risk of colorectal cancer: a nested case-control studyThe Lancet Oncology, 2006
- Depressive Symptoms and Prospective Incidence of Colorectal Cancer in WomenAmerican Journal of Epidemiology, 2005
- Use of Nonsteroidal Antiinflammatory Drugs and Risk of Breast Cancer: The Case-Control Surveillance Study RevisitedAmerican Journal of Epidemiology, 2005
- Fluoxetine increases extracellular levels of 3-methoxy-4-hydroxyphenylglycol in cultured COLO320 DM cellsCell Biochemistry and Function, 2004
- THE INFLUENCE OF SEROTONIN ON THE MITOTIC RATE IN THE COLONIC CRYPT EPITHELIUM AND IN COLONIC ADENOCARCINOMA IN RATSClinical and Experimental Pharmacology and Physiology, 1978